NCT02936895View on ClinicalTrials.gov

Vitamin D Supplementation and Respiratory Index of Severity in Children (RISC) in Pneumonia

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

September 30, 2016

Conditions
Pneumonia
Interventions
DRUG

Vitamin D3

vitamin D at a dose of 50,000 IU per day for 2 days

DRUG

Placebo

Placebo for 2 days

Trial Locations (1)

79176

Shahid Mohammadi hospital, Bandar Abbas

All Listed Sponsors
lead

Hormozgan University of Medical Sciences

OTHER

NCT02936895 - Vitamin D Supplementation and Respiratory Index of Severity in Children (RISC) in Pneumonia | Biotech Hunter | Biotech Hunter